Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Professor Denis Talbot who has been awarded the Lifetime Achievement Award from the British Thoracic Oncology Group (BTOG).



Denis Talbot

 

BTOG is the multi-disciplinary group for healthcare professionals involved with thoracic malignancies throughout the UK and Ireland. The group fosters the development of research, develops educational programs for healthcare professionals and represents the needs of patients to improve the outcomes of lung cancer.

Prof Talbot was awarded the Lifetime Achievement Award for his contributions to BTOG and the field of thoracic oncology.

Talking of the award, Denis said “I am honoured and delighted to receive this prestigious award. It has been a privilege to be part of BTOG which developed from the idea of a small group of physicians twenty years ago into a pre-eminent organisation in the UK, contributing significantly to education and research; and enhancing the multi-professional care and lives of people with thoracic malignancies.”

Similar stories

MP Anneliese Dodds tours Oxford cancer research

Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful work happening across departments in the field of cancer research.

Dr Lennard Lee awarded ACP McElwain Prize for contributions to medical oncology

Dr Lee (Department of Oncology) received the award to acknowledge his contributions during the COVID-19 pandemic, through the establishment of the UK Coronavirus Cancer Monitoring Project.

Professor Sibson secures further MRC DPFS funding

Prof. Sibson together with her co-applicants Prof. Anthony, Dr Campbell and Prof. Middleton have now been awarded a second MRC DPFS grant, for £3.3 million, to acquire further preclinical data to support the case for clinical translation, to develop the mutTNF production for human use and to undertake pre-clinical toxicology.